Category: CannabisNewsWire Release

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Leveraging DehydraTECH(TM) as It Looks to Tap into Various Markets

Lexaria Bioscience Corp. (NASDAQ: LEXX) has been pushing the boundaries of drug delivery through its patented DehydraTECH(TM) technology, which has evidenced more efficient delivery of active pharmaceutical ingredients (“APIs”) into the bloodstream while also increasing their bioavailability. “Its technology has seen application in pharmaceuticals, nutraceuticals, consumer packaged goods, and over-the-counter capsules, pills, tablets, and oral suspensions. Lexaria has explored its usage in the delivery of cannabinoids, nicotine, antivirals, PDE5 inhibitors, and more,” a recent article reads. “All of Lexaria’s efforts serve to demonstrate the superior performance of both its research program and its DehydraTECH drug delivery technology. By doing so, it is looking to tap into various markets, including but not limited to oral cannabinoids, oral mucosal nicotine, antivirals, human hormones, dementia, rheumatoid disease, and diabetes. Lexaria’s management hopes that, before the end of the 2022 calendar year, it will have built sufficient data to effect meaningful industry progress and sustainable increases in valuation to steer the conversation forward and allow for the greater adoption of DehydraTECH.”

To view the full article, visit https://cnw.fm/ZbMED

About Lexaria Bioscience Corp.

Lexaria’s patented drug delivery technology, DehydraTECH(TM), improves the way active pharmaceutical ingredients (“APIs”) enter the bloodstream by promoting more effective oral delivery. Since 2016, DehydraTECH has repeatedly demonstrated the ability to increase bio-absorption with cannabinoids and nicotine by up to 5-10x, reduce time of onset from 1 – 2 hours to minutes, and mask unwanted tastes; and is also being evaluated for orally administered anti-viral drugs, non-steroidal anti-inflammatory drugs (“NSAIDs”), PDE5 inhibitors and more. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood brain barrier. Lexaria operates a licensed in-house research laboratory and holds a robust intellectual property portfolio with 25 patents granted and over 50 patents pending worldwide. For more information, visit the company’s website at www.LexariaBioscience.com.

NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://cnw.fm/LEXX

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “Cannabis” to 844-397-5787 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Lift&Co. Expo Toronto Showcased Innovations Powering Future of the Cannabis Sector

Lift&Co. Expo, Canada’s no. 1 cannabis conference and trade show, hosted its latest event on May 12-15, 2022, at the Metro Toronto Convention Centre. The Lift Cannabis Business Conference (May 12) and Lift&Co. Expo in the Centre’s North Hall (May 13-15) featured leading-edge content and exhibitors from across North America to showcase information and innovations powering the future of the cannabis industry. Event sessions included Next Gen Cannabis Innovations, New Big Product Categories and Cannabis Market Trends & Predictions. The expo also shined the spotlight on additional forward-thinking programming across both the cannabis and psychedelics sectors and covered engaging topics such as Athletes & Cannabis, Cannabis Crystal Ball, New Psychedelics Data and The Future of Edibles. “We are continually inspired by Lift&Co. Expo, but this year was especially significant,” said Shawn Pierce, president of the expo’s producer, MCI Events. “As the cannabis landscape defines its ‘new normal’ in the pandemic era, we’re proud to cultivate a welcoming space for creating connections and reinvigorating the industry.”

To view the full press release, visit https://cnw.fm/CE373

About Lift&Co. Expo

Launched in 2016, Lift&Co. Expo is the original large-scale cannabis trade show in Canada, serving the cannabis community as both a meeting place and a destination for discovery. Each Lift&Co. Expo showcases leading-edge content and premiere exhibitors in a festival-like setting for thousands of cannabis industry retailers, producers, growers, investors and decision-makers. Lift&Co. Expo is proudly produced by MCI Events. Visit https://LiftExpo.ca for more information.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “Cannabis” to 844-397-5787 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

Lexaria Bioscience Corp. (NASDAQ: LEXX) Leveraging Growing Commercial Opportunities

  • Lexaria is a biotechnology company focused on licensing its proprietary DehydraTECH(TM) technology
  • The DehydraTECH technology has been proven to increase the bioavailability, speed of onset and brain absorption of APIs, and improve customer experiences by masking unwanted tastes
  • Lexaria has 25 patents granted worldwide and is pursuing numerous other pending patent applications
  • The company operates several subsidiary companies to focus on different commercial opportunities 

Ever since acquiring its first intellectual property (“IP”) that subsequently formed the basis of its first two patent application filings in 2014, biotechnology company Lexaria Bioscience (NASDAQ: LEXX) has grown the number of patents granted and patent applications exponentially, with 25 patents granted worldwide as of April 2022. The latest patent, the 10th granted in the United States, represents the first-ever patent for the use of DehydraTECH(TM) drug delivery technology in the enhanced delivery of antiviral drugs. Described by CEO Chris Bunka as “another validation of the versatility of our DehydraTECH drug technology,” the award of the IP protection marks a key step toward the ultimate monetization of DehydraTECH, according to an April 21 news release (https://cnw.fm/q8zmr).

This monetization, Lexaria’s annual report (Form 10-K filing) for the fiscal year ended August 2021 notes (https://cnw.fm/bCzFD), will be realized through the company’s focus on R&D and subsequent strategic partnerships with licensees. 

“Lexaria’s formulation and process-oriented operations are primarily conducted in its own laboratory and validated through third-party testing in preparation for partnering with industry leaders for adoption into their consumer products and/or drugs. Other than for R&D purposes, Lexaria does not produce, manufacture, market, or distribute drugs,” the filing reads. “Our business plan is currently focused on the development of strategic partnerships with licensees for our patented DehydraTECH technology in exchange for upfront and/or staged licensing fees and/or royalty payments over time.”

This focus has been influenced by numerous learnings through the years, some of which have involved experimentation with consumer product development that included brewed tea, coffee, protein bars, candies, drink mixes and several other product types. Discoveries made through innovative formulation work drives Lexaria’s technology and licensing strategies. 

According to the company’s most recent quarterly report for the three months ended February 28, 2022 (https://cnw.fm/dkWiT), Lexaria operates wholly owned subsidiaries focused on commercial opportunities which include –Lexaria Hemp Corp. focused on primarily US-based business-to-business (“B2B”) CBD opportunities;  Lexaria Pharmaceutical Corp., focused on registered drug development and advancement;  – and Lexaria Nicotine LLC., owned 16.67% by giant tobacco company Altria, which is focused on oral nicotine development as an alternative to combusted or vaped nicotine (https://cnw.fm/yVd9h).

Lexaria Pharmaceutical Corp. is investigating the potential for new registered drug products for hypertension, anti-viral treatments, epilepsy, some pharmaceutical applications of nicotine and other drug classes. This is where the largest long-term value creators for the Company are developed. Lexaria CanPharm Corp. operates a state-of-the-art Health Canada-licensed laboratory capable of developing novel cannabinoid and many other types of formulations for potential commercialization. Much of Lexaria’s most secret development work is carried out in that laboratory by trusted scientists employed by the Company. 

These subsidiaries sublicense DehydraTECH in their respective business sectors for the delivery of fat-soluble molecules and drugs to other companies which is Lexaria’s central plan to generate highly profitable revenue streams over long periods. Additionally, Lexaria will continue pursuing its pending patent applications to further bolster shareholder value. In addition, the company “will continue to seek beneficial acquisitions of intellectual property” if and when it believes it is advisable to do so.

Lexaria is a drug delivery company focused on developing and licensing its proprietary DehydraTECH technology for improved delivery and rapidity of bioactive compounds in orally delivered and topical products, as well as enhanced customer experiences by masking unwanted tastes. The DehydraTECH technology has been proven to enhance the bioavailability of a broad range of fat-soluble active pharmaceutical ingredients (“APIs”), thereby improving the way they enter the bloodstream, lowering dosing, and facilitating healthier oral ingestion methods. 

For more information, visit the company’s website at www.LexariaBioscience.com.

NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://cnw.fm/LEXX

About CBDWire

CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CBDWire.com

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer

Do you have questions or are you interested in working with CNW? Ask Our Editor

CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
Editor@CBDWire.com

CBDWire is part of the InvestorBrandNetwork.

420 with CNW — State Regulators Say Cannabis Banking Reform Will Ease Their Jobs

Last week, members of the Cannabis Regulators Association (CANNRA) penned a letter to leaders of congress. The letter’s primary signatories were regulators serving in Washington, Oregon, Nevada, Minnesota, Michigan, Hawaii and Georgia.

In the letter, the nonpartisan association outlined primary aspects of worry for the respective cannabis markets in their states. While it didn’t endorse the SAFE Banking Act directly, the letter did highlight that the absence of safe financial and banking services for marijuana industry actors and for the individuals involved in marijuana marketplaces was a public safety matter.

Legislators are currently holding a debate to attach the language of the SAFE Banking Act to the America COMPETES Act.

The letter stated that nearly all territories and member states of the association had been negatively affected by the lack of banking and financial services for marijuana businesses and those who worked with the marijuana industry. The primary issues the association identified concerned public security and safety, the need for small as well as minority-owned companies to have access to financial institutions and the lack of access to depository and banking services.

This banking issue has compelled many cannabis businesses into operating on cash-only terms, which makes them targets of criminal activity and threatens the public safety of communities and neighborhoods across the country.

In the letter, the association cited instances of recent robberies and violent crimes that took place at retail outlets in various states these last few months. The association noted that access to conventional banking services will strengthen efforts to prevent criminal enterprises and diversion and offer regulatory agencies better insight into legitimate operators.

The letter also highlighted that this issue was impacting small plus minority-owned businesses. The letter explained that while big businesses had the capability to identify and then use alternatives for financial transactions, small businesses struggled with this and were often left to operate on cash-only terms with no access to capital, which in turn affected their viability as well as success in the legal cannabis space.

CANNRA noted in the letter that this grew the already unequal playing field, which existed for small as well as minority-owned marijuana businesses.

Additionally, absence of access to safe banking also made it harder for marijuana regulators to promote equity and safeguard public health as well as consumer safety, in addition to promoting regulatory certainty with regard to those involved in the industry. CANNRA then urged Congress to accord prominence to policy approaches that promoted safe banking. This comes as more legislators, including Rep. Earl Blumenauer and Sen. Patty Murray, call for the advancement of the SAFE Baking Act.

Plant-touching and non-plant-touching companies alike, such as Advanced Container Technologies Inc. (OTC: ACTX), may be following the proceedings in the bicameral conference closely since the report the conference submits could have far-reaching consequences for the cannabis industry.

NOTE TO INVESTORS: The latest news and updates relating to Advanced Container Technologies Inc. (OTC: ACTX) are available in the company’s newsroom at https://cnw.fm/ACTX

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Commissioner Califf Admits FDA Hasn’t Done Much on CBD

While addressing a Congressional panel, FDA chief Dr. Robert Califf admitted that the agency he heads hasn’t been as fast as stakeholders may want as it handles matters of creating regulatory pathways for different products, including cannabidiol, extracted from hemp. This is despite the legalization at a federal level of hemp as well as its derivatives several years ago.

He admitted that while things look the same as they were when hemp was legalized back in 2018, his agency now has more data because it has been doing plenty of research. He added that most of the funds allocated to the FDA on matters of CBD regulation had gone to studying potential risks associated with the use of the different forms of CBD and application methods.

Califf told the subcommittee of the House Appropriations Committee that even if he was prepared to move ahead with finding ways to regulate CBD, it would be better if Congress gave the FDA additional powers on the matter beyond what it currently has. As a way of explaining what he meant, the commissioner observed that the current powers the FDA had in regulating foods on the one hand and drugs on the other hand are inadequate for this situation and something totally different (a new framework) would be required to get the needed regulations in place.

The FDA commissioner faced a barrage of questions from lawmakers on both sides of the political divide expressing their frustration about the agency’s inaction, which has resulted in widespread confusion among manufacturers and consumers.

Early this month, Rep. James Comer, a ranking GOP member of the House Oversight & Reform Committee, penned a letter to the chair of the committee requesting a sitting dedicated to holding the U.S. Food and Drug Administration responsible for its failure to formulate the necessary regulations so that the CBD sector can be overseen by this agency.

Subcommittee members also probed the commissioner about his agency’s view about kratom. He said kratom has some worrying side effects, which was why the FDA had tightened import controls on this “controversial tree.” The members, including Rep. Mark Pocan, responded to his answers by saying NIDA had a different perspective on kratom and that the FDA should see what NIDA had on this plant.

Commenting about the responses of the FDA commissioner during the Thursday hearing, several cannabis advocacy groups were cautiously optimistic that Califf would steer the agency appropriately on matters of regulating CBD. For example, the U.S. Hemp Roundtable took some encouragement from Califf’s tone, which signaled that he was personally unhappy that nothing had been done to regulate CBD since hemp had become federally legal.

The entire cannabis sector would likely benefit if there were federal regulations creating markets that entities such as American Cannabis Partners could serve from one coast to the other.

NOTE TO INVESTORS: The latest news and updates relating to American Cannabis Partners are available in the company’s newsroom at https://cnw.fm/ACP

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – CannabisNewsWire to Heighten Visibility of Upcoming CWCBExpo

CannabisNewsWire (“CNW”), a specialized communications platform for the cannabis sector and one of the 50+ brands of IBN (“InvestorBrandNetwork”), today announced that it will be collaborating with the organizers of CWCBExpo (Cannabis World Congress & Business Exposition) in its capacity as the official newswire for the June event. The conference is slated to take place June 2-4, 2022, at New York City’s Javits Convention Center, Hall 3A. Having earned a reputation as a premier B2B cannabis, CBD and hemp event, the upcoming CWCBExpo will feature influential speakers, interactive “talk show” and educational sessions, innovative product displays and exclusive networking opportunities to explore the potential of the cannabis market. “It is a real pleasure to partner with CannabisNewsWire and IBN once again, and we look forward to collaborating in the future too,” said Christine Ianuzzi, managing partner and show director of CWCBExpo. “IBN has an extensive network of brands working within the cannabis, CBD and hemp industries. Their collective network will heighten visibility for our sponsors, speakers and conference participants.”

To view the full press release, visit https://cnw.fm/AwUkI

About CannabisNewsWire

CannabisNewsWire (“CNW”), one of 50+ brands within IBN (“InvestorBrandNetwork”), is a specialized information service that (1) aggregates cannabis news; (2) provides CannabisNewsBreaks to quickly update investors in the space; (3) enhances corporate press releases; (4) provides social media distribution via IBN to millions of social media followers; and (5) delivers comprehensive corporate communication solutions. CNW is uniquely positioned in the cannabis market with a strong team of journalists and writers who can help private and public companies reach a wide audience of investors, consumers, journalists and the general public through its ever-growing dissemination network of 5,000+ key syndication outlets. CNW is bringing unparalleled visibility, recognition and content to the cannabis industry.

For more information, please visit www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “Cannabis” to 844-397-5787 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

The Cannabis World Congress & Business Exposition (‘CWCBExpo’) is the Pre-eminent Forum for Gaining a Foothold Within New York’s Fast-Accelerating Cannabis Sector

New York’s recreational and medical marijuana market is poised for historical growth amid rising public and political support for increased cultivation in the tri-state area. The Cannabis World Congress & Business Exposition (“CWCBExpo”), set to take place at New York City’s Javits Convention Center, Hall 3A on June 2-4, 2022, is the ideal forum for exploring industry best practices, business building and networking within this dynamic sector industry. In September 2021, adult New Yorkers could legally possess up to three ounces of cannabis for recreational use or up to 24 grams of concentrated cannabis in certain products such as oils. With the recent passing of a federal bill to legalize marijuana in the House of Representatives, combined with the New York administration’s approval of 36 new recreational cannabis cultivation licenses and as the first state to allow licensed hemp cultivators to grow adult-use marijuana, industry operations are forecast to see explosive revenue growth within the first year (https://cnw.fm/cfrc0).

The CWCBExpo, with a reputation for excellence as the leading forum in the cannabis, CBD, hemp and allied sectors, is favored throughout the ecosystem by dispensary owners, cultivators, manufacturers, investors, medical professionals, government regulators, attorneys, and entrepreneurs, is well-positioned as the ideal starting point to gain a foothold in New York’s fast-growing sector. The conference will host a series of roundtables, keynote addresses, and exciting conversations in a ‘talk show’ format with the top industry thought leaders. The thought leadership series will be segmented across each day and include ‘Investing and Industry Progress,’ ‘Policy and Legislation,’ and ‘Cannabis and Lifestyle,’ and address opportunities and challenges within the ecosystem. The sessions detail both the local landscape as well as the national outlook. 

The full conference agenda can be found at: https://cwcbexpo.com/conference-highlights/ 

In addition to the wide array of expert speakers and leading business people, the summit will host hundreds of exhibitors who will showcase cutting-edge product innovations and the latest services. 

The event shall also host a Networking Mixer on Thursday, June 2, from 5 – 7 pm, sponsored by Weedmaps, so that attendees can network, or relax ahead of the rest of the conference.

On Friday, June 3, from 6 – 10 pm, CWCBExpo will host the Industry Yacht Party, where attendees can eat, drink and dance with their peers while taking in the majestic New York City skyline. This is a premier networking and deal-making opportunity.

The Networking Mixer and Industry Yacht Party require separate tickets and are open only to registered CWCBExpo attendees. Get your tickets now at the best price!

For further information on the CWCBExpo and to register, visit https://cwcbexpo.com/

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW — DEA-Approved Cannabis Cultivator Debuts on NASDAQ

Bright Green Corp., a Florida-based cannabis company, made history last week by being the first “plant-touching” company to list its shares on a major securities exchange within the United States. The company, which boasts of being in possession of conditional approval from the U.S. Drug Enforcement Administration to grow research-grade marijuana, started trading on the NASDAQ exchange under the ticker BGXX on Tuesday last week.

The exchange had earlier set $8 as the reference price for a share of this company, but when trading opened on Tuesday, the stocks started trading at $15.99. In the course of the day, the price climbed up to a maximum price of $36.44 though it eventually ended the day at $25.25. This closing price depicted a 216% increase from the reference price at which a share was set just before trading started.

It should be noted that BGXX was categorized as a direct listing. In such a listing, the current shareholders of a company sell some of their shares, and the company doesn’t receive the proceeds from such a sale of stocks. SEC filings indicate that Bright Green’s shareholders agreed to sell 158.2 million shares.

At the close of the company’s first day of trading, Bright Green had a $4 billion valuation on the basis of the price at which a share closed. This is huge given that Bright Green hasn’t started making sales. The company is constructing a cultivation and processing facility worth $300 million in Grants, New Mexico.

At the moment, the major shareholders in Bright Green are Lynn Stockwell, a director in the company owning 69.6 million shares, and Terry Rafih, also a director who owns a little more than 20 million shares. Edward Robinson, the CEO of the company, currently owns 5 million of the company’s shares while his wife has 605,000 company shares to her name.

Bright Green says it plans to commercialize cannabis products, but only after the U.S. federal government has ended the prohibition of marijuana. This is one of the key positions the company took in order to distinguish itself from other marijuana companies that are operating under state laws. The filings Bright Green made to the Securities and Exchange Commission emphasize this distinction.

For decades, only the University of Mississippi had a facility to grow DEA-approved marijuana for research purposes. That monopoly is being dismantled, and Bright Green is one of the applicants that have been given conditional approval to grow marijuana for research purposes.

The cannabis industry looks forward to the time when domestic companies such as Cannabis Strategic Ventures Inc. (OTC: NUGS) can access the huge amounts of capital available to companies that list on the NASDAQ, NYSE and other securities exchanges in the United States.

NOTE TO INVESTORS: The latest news and updates relating to Cannabis Strategic Ventures Inc. (OTC: NUGS) are available in the company’s newsroom at http://cnw.fm/NUGS

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Study Finds That Cannabis Legalization Is Associated with Reduced Opioid, Nicotine, Alcohol Use

New research has found that the legalization of cannabis is associated with reduced use of nonprescription opioids, nicotine and alcohol. The study was conducted by researchers at the University of Washington. Its findings were reported in the “Journal of Adolescent Health.”

For their study, the researchers conducted an analysis of data on trends of substance use in the period between 2014 and 2019. The data, which was obtained from more than 12,000 adults, led to the discovery that individuals who were 21 to 25 years of age were less prone to consuming more “dangerous” drugs after they were legalized within the state.

The study abstract stated that the putting into operation of legalized recreational cannabis coincided with reductions in cigarette and alcohol use and the misuse of pain relievers, which doesn’t align with concerns that legalization would lead to an increase of the use of the aforementioned substances. The study also noted that the weakening link of the use of marijuana with the use of other substances among individuals who are 21 to 25 years old suggested increased need of marijuana-specific efforts for prevention and treatment.

The study did find that the rates of using e-cigarettes grew among this age group post-2016.

In a blog post, NORML deputy director Paul Armentano stated that data from legalization states disputed claims that marijuana was a gateway drug, with marijuana regulation being connected to the reduced use of other substances, such as various prescription medications. A separate study also concluded that the legalization of cannabis was linked to a reduction in the use of prescription drugs indicated for treating conditions such as seizures, pain, sleep and anxiety.

In addition to this, several other studies have identified links between decreased pharmaceutical prescriptions with the enactment of medical marijuana legalization at state level. In 2021, one study found that the use of medical cannabis was linked to an increase in quality of life and significant decreases in addiction to opioids and other prescription medications.

Additionally, a meta-study whose findings were released in 2020 suggested that cannabis could be used as an alternative to opioid-based painkillers because it demonstrated promise as a treatment alternative against chronic pain. That year, scientists also published findings from a study which demonstrated that marijuana could alleviate symptoms of opioid withdrawal.

Furthermore, in 2019, researchers determined that states with legal access to cannabis experienced reductions in opioid prescriptions. Separate research that was released months before this study demonstrated that the daily consumption of cannabis was linked to decreased opioid consumption among patients with chronic pain.

All this scientific data suggests that the cannabis products sold in legal markets by companies such as Flora Growth Corp. (NASDAQ: FLGC) are more beneficial than industry detractors would want to admit.

NOTE TO INVESTORS: The latest news and updates relating to Flora Growth Corp. (NASDAQ: FLGC) are available in the company’s newsroom at https://cnw.fm/FLGC

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Advanced Container Technologies Inc.’s (ACTX) GrowPods Can Provide Compelling Experience of ‘Buying Right off the Vine’

Advanced Container Technologies (OTC: ACTX) today announced that its GrowPods — innovative modular hydroponic farms — can give grocers the ability to grow and sell ultra-clean and fresh strawberries and leafy lettuce, kale and micro-greens from a self-contained unit that can be located as nearby as the store’s parking lot. The announcement includes examples of grocers “taking farm-to-table to a whole new level,” including, according to Progressive Grocer, Kroger Company (NYSE: KR) providing customers with hydroponic produce right at the point of purchase. “Our modular hydroponic farms not only produce ultra-clean, vine-ripened strawberries and leafy greens, but also provide other sustainability benefits such as cutting freight emissions, lowering water usage and prolonging shelf life,” said Doug Heldoorn, CEO of Advanced Container Technologies. “Additionally, that experience of going into a grocer and essentially buying right off the vine is compelling from a customer experience standpoint.”

To view the full press release, visit https://cnw.fm/pI4gg

About Advanced Container Technologies Inc.

Advanced Container Technologies is in the business of selling and distributing self-contained, automated, indoor “micro-farms” called Grow Pods, along with related equipment and supplies. Additionally, the company designs and sells patented proprietary medical-grade plastic containers, known as the Medtainer(R), that store and grind pharmaceuticals, herbs, teas and other solids or liquids. For more information, visit the company’s website at www.AdvancedContainerTechnologies.com.

NOTE TO INVESTORS: The latest news and updates relating to ACTX are available in the company’s newsroom at https://cnw.fm/ACTX

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “Cannabis” to 844-397-5787 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.